OVERVIEW

Pharmacy Law: Regulatory Developments Affecting Pharmacy Practice is organized by The Rx Consultant and will be held from Jul 06, 2017 - Jul 06, 2020.

The target audience for this medical event is accredited program is targeted to pharmacists and nurses. This CME Conference has been approved for a maximum of 2.0 CE Credits.

Course Description:
The past few years have seen a number of legislative and regulatory changes at the federal level; both with the Food and Drug Administration (FDA) and the Drug Enforcement Administration (DEA). This article will address key changes impacting pharmacy practice in the areas of compounding, drug supply chain security, biosimilars, and the regulation of controlled substances in order to prevent diversion and abuse.

Course Objectives:
• Discuss the differences between traditional compounding and compounding at outsourcing facilities and the regulations that apply to each. Compare sections 503A and 503B of the Compounding Quality Act.
• Explain the Drug Supply Chain Security Act as it applies to various parts of the pharmaceutical distribution chain and recognize the key provisions of the Act to be implemented by 2023.
• Define what is meant by a biosimilar product, and discuss the FDA’s criteria for interchangeability.
• Apply the Drug Disposal Act implemented in 2014 to your practice. Identify the allowed methods of controlled substance disposal and requirements for each.
• Summarize the advantages of the rescheduling of hydrocodone combination products to Schedule II, and the regulation under the Comprehensive Addiction and Recovery Act (CARA) regarding partial filling of Schedule II drugs.

Additional details will be posted as soon as they are available.